GO:0090533 cation-transporting ATPase complex: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0090533 (cation-transporting ATPase complex) is a cellular component defined as a protein complex that carries out the reaction ATP + H2O + cation(out) = ADP + phosphate + cation(in).
• These complexes are molecular machines that couple ATP hydrolysis to the movement of cations across membranes, a fundamental process in physiology and disease.
• Key members include P-type ATPases such as the Na+/K+-ATPase, H+/K+-ATPase, and Ca2+-ATPases, as well as F-type and V-type ATPases.
• Dysfunction of cation-transporting ATPase complexes is linked to neurological disorders such as Parkinson's disease, where dopamine toxicity and autophagy modulation are implicated.
• Studying these complexes requires integrated approaches including CRISPR knockout, point mutation, knock-in, overexpression, and advanced proteomics and imaging.
• EDITGENE provides comprehensive CRISPR services to model cation-transporting ATPase complex genes for mechanistic and therapeutic research.
Description
The cation-transporting ATPase complex (GO:0090533) is a cellular component that executes a vital biochemical reaction: the hydrolysis of ATP to ADP and phosphate, coupled to the transport of a cation from the outside to the inside of a membrane. This definition, from the Gene Ontology, captures a diverse family of membrane-embedded protein machines that maintain ion gradients essential for life. These complexes are found in all kingdoms of life, from bacteria to humans, and are central to processes such as nerve impulse transmission, muscle contraction, and nutrient uptake. Understanding their structure, function, and regulation is a major focus of biomedical research because their dysfunction underlies a wide range of diseases, including neurological disorders and cardiovascular conditions. In this article, we explore the cation-transporting ATPase complex in depth, covering its definition, components, mechanisms, and the cutting-edge research methods used to study it, with a focus on how CRISPR-based models can accelerate discovery.
cation-transporting ATPase complex At A Glance
| GO ID | GO:0090533 |
|---|---|
| GO term | cation-transporting ATPase complex |
| Ontology | cellular_component |
| Synonym | None |
| Definition | Protein complex that carries out the reaction: ATP + H2O + cation(out) = ADP + phosphate + cation(in). |
| Major function | ATP-dependent cation transport across membranes |
| Examples | Na+/K+-ATPase, H+/K+-ATPase, Ca2+-ATPase, F0F1-ATPase |
| Cellular locations | Plasma membrane, organelle membranes |
| Associated diseases | Parkinson's disease, cardiovascular disorders, cancer |
What Is GO:0090533?
According to the Gene Ontology, GO:0090533 (cation-transporting ATPase complex) is a protein complex that carries out the reaction: ATP + H2O + cation(out) = ADP + phosphate + cation(in). In simpler terms, it is a molecular assembly that uses the energy from ATP to pump positively charged ions (cations) across a membrane, moving them from the outside to the inside of a cell or organelle. This definition encompasses a variety of ATP-powered ion pumps, including P-type, F-type, and V-type ATPases, which share the common function of cation transport but differ in structure and mechanism.
Why Is cation-transporting ATPase complex Important in Cell Biology?
The cation-transporting ATPase complex is fundamental to cellular physiology because it establishes and maintains electrochemical gradients of cations such as sodium, potassium, calcium, and protons across biological membranes. These gradients drive essential processes including nutrient transport, signal transduction, and cell volume regulation. Consequently, dysfunction of these complexes is implicated in a broad spectrum of human diseases, from neurodegenerative disorders like Parkinson's disease to cardiovascular diseases and cancer. Moreover, these complexes are targets for widely used drugs, such as cardiotonic steroids (e.g., ouabain) that inhibit the Na+/K+-ATPase. Therefore, understanding their biology is critical for both basic research and therapeutic development.
• Maintains ion homeostasis essential for nerve impulse conduction and muscle contraction.
• Regulates cellular pH and volume through proton and cation transport.
• Provides energy for secondary active transport of nutrients and metabolites.
• Involved in the pathophysiology of Parkinson's disease via dopamine toxicity and autophagy.
• Targeted by therapeutic drugs such as ouabain for heart conditions.
• Plays a role in multidrug resistance in cancer and pathogens.
• Essential for lysosomal function and autophagy regulation.
• Mutated in inherited disorders like familial hemiplegic migraine and deafness.
• Key to plant and microbial physiology, impacting agriculture and infectious disease.
• Serves as a model system for studying membrane protein structure and mechanism.
What Happens During cation-transporting ATPase complex?
ATP Binding and Hydrolysis
In simple terms: The complex grabs an ATP molecule and breaks it apart to release energy.
The catalytic cycle begins with the binding of ATP to the nucleotide-binding domain of the ATPase. This is followed by hydrolysis of ATP into ADP and inorganic phosphate, which releases free energy. This energy is used to drive conformational changes in the protein that lead to cation transport. For example, in the Na+/K+-ATPase, ATP hydrolysis is tightly coupled to the phosphorylation of a conserved aspartate residue, forming a high-energy acylphosphate intermediate.
Cation Binding and Occlusion
In simple terms: The complex captures the ion it needs to transport and hides it inside itself.
After phosphorylation, the ATPase undergoes a conformational change that exposes high-affinity binding sites for the cation to be transported. For instance, in the Na+/K+-ATPase, three intracellular Na+ ions bind to the cytoplasmic side. The binding sites then become occluded, meaning the ions are trapped within the protein and cannot exchange with the surrounding solution. This occlusion is a critical step that ensures unidirectional transport and prevents back-leakage.
Conformational Transition and Cation Release
In simple terms: The complex changes shape to push the ion across the membrane and release it on the other side.
The energy from ATP hydrolysis drives a major conformational change from the E1 to the E2 state. In the E2 state, the affinity for the transported cation decreases dramatically, causing its release into the extracellular or luminal space. For the Na+/K+-ATPase, this step is coupled to the binding of extracellular K+ ions, which are then transported back into the cell in a subsequent half-cycle. This alternating-access mechanism is a hallmark of P-type ATPases.
Counter-transport and Cycle Completion
In simple terms: The complex brings a different ion back in to reset itself for the next round.
Many cation-transporting ATPases, such as the Na+/K+-ATPase, are exchange pumps that transport one cation out and another in. After releasing Na+ outside, the enzyme binds K+ from the extracellular side, which triggers dephosphorylation and a return to the E1 conformation. This completes the cycle and prepares the enzyme for another round of ATP hydrolysis. The stoichiometry is typically 3 Na+ out and 2 K+ in per ATP hydrolyzed, contributing to the generation of the membrane potential.
Key Genes Involved in GO:0090533 cation-transporting ATPase complex
The cation-transporting ATPase complex comprises a diverse array of genes encoding catalytic subunits, regulatory subunits, and accessory proteins that assemble into functional pumps.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ATP1A1 | Catalytic alpha subunit of Na+/K+-ATPase | Target of ouabain; implicated in cancer and neurological disorders |
| ATP1A2 | Catalytic alpha subunit of Na+/K+-ATPase | Mutations cause familial hemiplegic migraine and epilepsy |
| ATP1A3 | Catalytic alpha subunit of Na+/K+-ATPase | Mutations linked to rapid-onset dystonia-parkinsonism |
| ATP1B1 | Beta subunit of Na+/K+-ATPase | Regulates pump stability and cell adhesion |
| ATP4A | Gastric H+/K+-ATPase alpha subunit | Target for proton pump inhibitors; role in acid secretion |
| ATP4B | Gastric H+/K+-ATPase beta subunit | Required for pump maturation and function |
| ATP2A1 | SERCA1 calcium ATPase | Regulates muscle contraction; mutations cause Brody disease |
| ATP2A2 | SERCA2 calcium ATPase | Mutations cause Darier disease; involved in cardiac function |
| ATP2B1 | Plasma membrane Ca2+-ATPase | Maintains calcium homeostasis; linked to hypertension |
| ATP7A | Copper-transporting ATPase | Mutations cause Menkes disease |
| ATP7B | Copper-transporting ATPase | Mutations cause Wilson disease |
| ATP6V1A | V-ATPase catalytic subunit | Lysosomal acidification; implicated in autophagy |
| ATP6V0A1 | V-ATPase a subunit | Neurodegeneration and lysosomal storage disorders |
| F0F1-ATPase | Bacterial ATP synthase | Model for rotary catalysis and antibiotic targets |
| ATP13A2 | P-type ATPase (PARK9) | Mutations cause Kufor-Rakeb syndrome, a form of Parkinsonism |
| ATP8B1 | P-type ATPase (FIC1) | Mutations cause progressive familial intrahepatic cholestasis |
| ATP10A | P-type ATPase | Associated with autism and lipid transport |
| ATP11A | P-type ATPase | Phospholipid flippase; role in apoptosis |
How Is cation-transporting ATPase complex Regulated?
The activity of cation-transporting ATPase complexes is tightly regulated at multiple levels. For example, the Na+/K+-ATPase is regulated by hormones such as aldosterone and insulin, which modulate its trafficking and activity. In the brain, dopamine and its metabolites can influence the function of these pumps, and autophagy pathways are known to regulate the turnover of damaged ATPases. Additionally, the expression of ATPase genes can be controlled by transcription factors and microRNAs, and their activity can be modulated by post-translational modifications including phosphorylation and ubiquitination. In pathogenic organisms like Plasmodium falciparum, cation-transporting ATPases are regulated in response to host signals and are essential for parasite survival.
cation-transporting ATPase complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ATP13A2 | Kufor-Rakeb syndrome (Parkinsonism) | Knockout iPSC-derived neurons; point mutation knock-in mice |
| ATP1A2 | Familial hemiplegic migraine | Knock-in mice with patient mutations; overexpression in cell lines |
| ATP7B | Wilson disease | Liver-specific knockout mice; patient-derived hepatocytes |
| ATP2A2 | Darier disease | Keratinocyte knockout models; knock-in mice |
| ATP6V1A | Lysosomal storage disorders | Neuronal knockout; tagged knock-in for live imaging |
Neurodegenerative Disorders
Dysfunction of cation-transporting ATPase complexes is increasingly recognized in neurodegenerative diseases. In Parkinson's disease, mutations in ATP13A2 (PARK9) cause early-onset parkinsonism with pyramidal degeneration and cognitive impairment. Moreover, dopamine metabolism generates reactive oxygen species that can damage ATPases, contributing to neuronal death. Autophagy, which clears damaged organelles and proteins, is impaired in Parkinson's disease, and targeting autophagy with small molecules has shown therapeutic potential. The Na+/K+-ATPase is also critical for maintaining neuronal excitability, and its dysfunction can lead to excitotoxicity.
Cardiovascular and Metabolic Diseases
The Na+/K+-ATPase is a key regulator of cardiac contractility and is the target of cardiotonic steroids like ouabain, which are used to treat heart failure. Mutations in ATP1A2 and ATP1A3 are associated with familial hemiplegic migraine and rapid-onset dystonia-parkinsonism, respectively. In addition, calcium-transporting ATPases such as SERCA2 are essential for cardiac muscle relaxation, and their dysfunction contributes to heart failure. Copper-transporting ATPases (ATP7A and ATP7B) are defective in Menkes and Wilson diseases, leading to copper accumulation and organ damage.
Infectious Diseases and Cancer
Cation-transporting ATPases are essential for the survival of pathogens such as Plasmodium falciparum, the malaria parasite, making them potential drug targets. In cancer, the Na+/K+-ATPase is involved in cell proliferation and apoptosis, and its inhibition by ouabain can trigger cell death. Furthermore, V-ATPases are upregulated in many cancers and contribute to drug resistance by acidifying the tumor microenvironment. Targeting these complexes is an active area of therapeutic development.
From cation-transporting ATPase complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of complete loss of ATP1A1 on cell viability? | CRISPR knockout in HeLa or HEK293 cells |
| How does a specific patient mutation in ATP1A2 affect pump function? | Point mutation knock-in in isogenic cell lines |
| Can we visualize the localization of ATP7B in live cells? | Knock-in of fluorescent tag (e.g., GFP) at the endogenous locus |
| Does overexpression of ATP2A2 rescue calcium handling in disease models? | Lentiviral overexpression in patient-derived cells |
| What are the interactors of ATP6V1A in neurons? | Proximity labeling (BioID) with knock-in tagged protein |
| Can we screen for drugs targeting the Na+/K+-ATPase? | CRISPR library screening for resistance or sensitivity |
How to Study the cation-transporting ATPase complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss of gene function | Determine essentiality of ATPase genes |
| CRISPR point mutation knock-in | Effect of specific mutations | Model patient-derived mutations |
| CRISPR knock-in of tags | Protein localization and interactions | Live-cell imaging and proteomics |
| Overexpression | Gain of function | Rescue experiments and drug screening |
| RNA-seq | Gene expression profiles | Identify dysregulated ATPases in disease |
| Proteomics | Protein abundance and modifications | Map subunit composition and interactors |
| Live-cell imaging | Ion flux and protein dynamics | Measure pump activity in real time |
| CRISPR library screening | Genome-wide functional interactions | Identify modifiers of ATPase function |
CRISPR-Cas9 Genome Editing
CRISPR-Cas9 is a powerful tool to create knockout, point mutation, and knock-in models of cation-transporting ATPase genes. For example, knockout of ATP1A1 can reveal its essential role in cell survival, while knock-in of disease-associated mutations (e.g., in ATP1A2) allows study of their functional consequences in isogenic backgrounds. These models are invaluable for dissecting the molecular mechanisms of ATPase function and for drug discovery.
Proteomics and Interactomics
Mass spectrometry-based proteomics can identify the subunit composition of cation-transporting ATPase complexes and their interacting partners. Affinity purification of tagged ATPase subunits followed by LC-MS/MS has revealed novel regulatory proteins and post-translational modifications. Proximity labeling techniques such as BioID can map the interactome in living cells, providing spatial and temporal information.
Live-Cell Imaging and Transport Assays
Fluorescent indicators for ions (e.g., Fluo-4 for Ca2+, PBFI for K+) and pH-sensitive dyes enable real-time monitoring of cation transport in live cells. Knock-in of fluorescently tagged ATPases allows visualization of their trafficking and localization. These methods are complemented by electrophysiology to measure pump currents directly.
Transcriptomics and Functional Genomics
RNA-seq can profile the expression of ATPase genes across tissues and disease states, while CRISPR library screening can identify genes that modulate ATPase function or drug sensitivity. For instance, genome-wide screens have uncovered regulators of Na+/K+-ATPase trafficking and stability. These approaches are essential for understanding the broader cellular network involving cation-transporting ATPases.
How CRISPR Can Be Used to Study GO:0090533 cation-transporting ATPase complex
Knockout
CRISPR knockout of cation-transporting ATPase genes is used to study their essentiality and cellular functions. For example, knockout of ATP1A1 in human cells leads to cell death, highlighting its critical role in ion homeostasis. Knockout models can also reveal compensatory mechanisms and identify synthetic lethal interactions, which are valuable for drug target discovery.
Point Mutation
Point mutation knock-in allows the introduction of specific disease-associated mutations into the endogenous gene locus. This is particularly useful for studying ATP1A2 mutations that cause familial hemiplegic migraine, as it preserves native expression levels and regulation. Such models can reveal subtle functional defects that are not apparent in overexpression systems.
Knock-in
Knock-in of reporter tags (e.g., GFP, HA, or split tags) enables visualization and purification of endogenous ATPase complexes. For instance, tagging ATP7B with a fluorescent protein allows tracking of its copper-dependent trafficking in live cells. Knock-in of inducible degrons (e.g., auxin-inducible degron) provides temporal control over protein depletion, which is useful for studying essential genes.
Overexpression
Overexpression of wild-type or mutant ATPases is used to study gain-of-function effects and to rescue loss-of-function phenotypes. For example, overexpression of SERCA2a in cardiac cells improves calcium handling and contractility, and is being explored as a gene therapy for heart failure. Overexpression models are also valuable for drug screening and structure-function studies.
How EDITGENE Supports cation-transporting ATPase complex Research
Researchers studying cation-transporting ATPase complex-related genes often need to determine whether a candidate gene is causally involved in a specific cellular process or disease. This requires precise genetic models that can knockout, mutate, tag, or overexpress the gene of interest in relevant cell types. EDITGENE provides a comprehensive suite of CRISPR services to accelerate such research, from single gene editing to genome-wide screening.
Contact EDITGENE today to design your custom CRISPR model for cation-transporting ATPase complex research.
Frequently Asked Questions About cation-transporting ATPase complex
What is GO:0090533 cation-transporting ATPase complex?
GO:0090533 is a Gene Ontology cellular component term that defines a protein complex carrying out the reaction ATP + H2O + cation(out) = ADP + phosphate + cation(in), i.e., an ATP-powered cation pump.
What genes are involved in cation-transporting ATPase complex?
Genes include ATP1A1, ATP1A2, ATP1A3, ATP1B1, ATP4A, ATP4B, ATP2A1, ATP2A2, ATP2B1, ATP7A, ATP7B, ATP6V1A, ATP6V0A1, ATP13A2, and many others encoding P-type, F-type, and V-type ATPases.
What diseases are associated with cation-transporting ATPase complex dysfunction?
Diseases include Parkinson's disease, familial hemiplegic migraine, Wilson disease, Menkes disease, Darier disease, and cardiovascular disorders.
How can CRISPR be used to study cation-transporting ATPase complex?
CRISPR can create knockout, point mutation, knock-in, and overexpression models to dissect gene function, model disease mutations, and perform drug screens.
What is the function of the Na+/K+-ATPase?
The Na+/K+-ATPase is a cation-transporting ATPase that pumps three Na+ ions out and two K+ ions in per ATP hydrolyzed, maintaining the membrane potential essential for nerve and muscle function.
Which ATPase is targeted by ouabain?
Ouabain targets the Na+/K+-ATPase, stabilizing its structure and inhibiting its activity, which is used therapeutically for heart conditions.
What is the role of ATP13A2 in Parkinson's disease?
Mutations in ATP13A2 cause Kufor-Rakeb syndrome, a form of early-onset Parkinsonism, and impair lysosomal function and autophagy.
How does the cation-transporting ATPase complex work?
It couples ATP hydrolysis to conformational changes that transport cations across membranes, often exchanging one cation for another, as in the Na+/K+-ATPase.
What are the subunits of the Na+/K+-ATPase?
The Na+/K+-ATPase consists of a catalytic alpha subunit (e.g., ATP1A1) and a regulatory beta subunit (e.g., ATP1B1), which are required for proper folding and function.
What research methods are used to study cation-transporting ATPases?
Methods include CRISPR genome editing, live-cell imaging, proteomics, electrophysiology, and RNA-seq, among others.
Conclusion
The cation-transporting ATPase complex (GO:0090533) is a fundamental cellular machine that powers ion homeostasis and drives numerous physiological processes. Its dysfunction is linked to a wide range of diseases, from neurodegeneration to cardiovascular disorders, making it a prime target for therapeutic intervention. Advances in CRISPR-based genome editing and other technologies are enabling researchers to dissect the molecular details of these complexes with unprecedented precision. EDITGENE is committed to supporting this research by providing high-quality CRISPR services tailored to cation-transporting ATPase genes.
References
- 1. Zhang K et al.. 2021. Targeting autophagy using small-molecule compounds to improve potential therapy of Parkinson's disease.. Acta Pharm Sin B 11(10):3015-3034 PMID: 34729301
- 2. Dyer M et al.. 1996. Analysis of a cation-transporting ATPase of Plasmodium falciparum.. Mol Biochem Parasitol 78(1-2):1-12 PMID: 8813672
- 3. Noumi T et al.. 1988. A homologous sequence between H+-ATPase (F0F1) and cation-transporting ATPases. Thr-285----Asp replacement in the beta subunit of Escherichia coli F1 changes its catalytic properties.. J Biol Chem 263(18):8765-70 PMID: 2897962
- 4. Ray TK et al.. 1986. K+-stimulated p-nitrophenyl phosphatase is not a partial reaction of the gastric (H+ + K+)-transporting ATPase. Evidence supporting a new model for the univalent-cation-transporting ATPase systems.. Biochem J 233(1):231-8 PMID: 3006658
- 5. Segura-Aguilar J et al.. 2014. Protective and toxic roles of dopamine in Parkinson's disease.. J Neurochem 129(6):898-915 PMID: 24548101
- 6. Miles AJ et al.. 2013. Stabilisation of Na,K-ATPase structure by the cardiotonic steroid ouabain.. Biochem Biophys Res Commun 435(2):300-5 PMID: 23618866
- 7. Puts CF et al.. 2012. Mapping functional interactions in a heterodimeric phospholipid pump.. J Biol Chem 287(36):30529-40 PMID: 22791719
- 8. Kirdat K et al.. 2024. Draft genome sequence of 'Candidatus Phytoplasma asteris,' strain SW86 associated with sandal spike disease (SSD).. 3 Biotech 14(4):109 PMID: 38481824
